Edelman Joseph 的 Form 4 申報
Adma Biologics, Inc.（ADMA），2021/8/19 申報
- 申報編號
- 0001062993-21-007800
- 申報時間
- 2021/8/19 19:58 ET
- 交易日
- 2021/8/17-8/19
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 3 筆非衍生性交易。公開市場賣出合計 $233.4 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Edelman JosephCIK 0001164426 | 持股 10% 以上大股東 |
| Perceptive Advisors LLCCIK 0001224962 | 持股 10% 以上大股東 |
| Perceptive Life Sciences Master Fund LtdCIK 0001249675 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.41, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range.
表 I 有 1 筆交易的價格引用這則附註。
- F2
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.26 to $1.33, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.22 to $1.27, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within such range.
表 I 有 1 筆交易的價格引用這則附註。